Cite
HARVARD Citation
Ishida, T. et al. (2022). Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. Japanese journal of clinical oncology. pp. 1446-1449. [Online].